Hims & Hers Health, Inc. officer Oluyemi Okupe filed a Form 144 notice on November 17, 2026, proposing to sell 3,518 Class A shares on NYSE under a Rule 10b5-1 plan.
Key Highlights
- Proposed sale: Oluyemi Okupe intends to sell 3,518 Class A shares with an aggregate market value of $65,188.54.
- Source of shares: The shares were acquired on November 15, 2026, through restricted stock vesting from the issuer, classified as compensation.
- 10b5-1 plan: The notice references a Rule 10b5-1 plan adopted on May 20, 2026.
- Prior sales in past 3 months: Okupe sold 12,313 shares on September 17, 2026 (gross proceeds $354,860.66), 29,277 shares on September 22, 2026 (gross proceeds $876,846.15), and 2,000 shares on October 1, 2026 (gross proceeds $59,400.00).
- Shares outstanding: According to the filing, 226,034,799 Class A shares were outstanding at the time of notice.
- Broker: Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI 02917, is named as the broker for the proposed sale.
Okupe's Proposed Class A Share Sale at Hims & Hers Health
According to the Form 144 filed with the U.S. Securities and Exchange Commission on November 17, 2026, Oluyemi Okupe, an officer of Hims & Hers Health, Inc. (NYSE:HIMS), proposes to sell 3,518 Class A shares through Fidelity Brokerage Services LLC. The filing reports an aggregate market value of $65,188.54 for the proposed sale, with an approximate sale date of November 17, 2026.
The filing discloses that the 3,518 shares were acquired on November 15, 2026, via restricted stock vesting directly from the issuer, with the nature of payment listed as compensation. Okupe's notice states that the proposed sale is being conducted pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026. The filing was signed by Wade Moss as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Oluyemi Okupe.
The filing also details prior sales by Okupe over the past three months. On September 17, 2026, 12,313 Class A shares were sold for gross proceeds of $354,860.66. On September 22, 2026, 29,277 shares were sold for gross proceeds of $876,846.15. On October 1, 2026, 2,000 shares were sold for gross proceeds of $59,400.00. The issuer's address is listed as 2269 Chestnut St, #523, San Francisco, California 94123.
What Was Disclosed
The Form 144 notice discloses Oluyemi Okupe's proposed sale of 3,518 Class A shares of Hims & Hers Health, Inc. on NYSE, acquired through restricted stock vesting on November 15, 2026, under a 10b5-1 plan adopted May 20, 2026.




Please wait processing your request...